Skip to main content
$37.12 -$0.60 (-1.6%)

04:15 PM EDT on 09/24/20

Boston Scientific Corp. (NYSE:BSX)

CAPS Rating: 4 out of 5

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

Current Price $37.12 Mkt Cap $54.0B
Open $37.43 P/E Ratio 13.05
Prev. Close $37.72 Div. (Yield) $0.00 (0.0%)
Daily Range $36.86 - $37.54 Volume 1,920,356
52-Wk Range $24.10 - $46.62 Avg. Daily Vol. 7,305,160

Caps

How do you think NYSE:BSX will perform against the market?

Add Stock to CAPS Watchlist

All Players

732 Outperform
186 Underperform
 

All-Star Players

139 Outperform
17 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:BSX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBreakerJava (99.83)
Submitted July 12, 2009

They are generating lots of cash and rapidly paying down debt. Insider selling last fall was induced by the financial crisis and does not reflect a lack of faith in the business. Gross margin of 70%. They will likely benefit from universal health… More

dickshatband (< 20)
Submitted March 15, 2010

Another major blunder from a company that knows all to well the consequences of such a major mistake. Please take my advice when I tell you this ship is sinking fast.

Recent Community Commentary

Read the most recent pitches from players about BSX.

Recs

0
Member Avatar TMFacarchidi (50.08) Submitted: 7/21/2020 5:51:34 PM : Underperform Start Price: $37.26 NYSE:BSX Score: +0.27

Shrinking quarterly earnings growth, little media coverage, and controlling debt by issuing new stock.

Recs

0
Member Avatar TheDistilled2 (< 20) Submitted: 3/31/2020 5:09:47 PM : Outperform Start Price: $31.54 NYSE:BSX Score: -13.04

good stats besides high p/c (209) and debt/eq .72, lt debt/eq .62

Recs

0
Member Avatar TMFAdriaCimino (49.65) Submitted: 2/20/2020 3:59:14 AM : Outperform Start Price: $42.31 NYSE:BSX Score: -8.25

Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one.

Leaderboard

Find the members with the highest scoring picks in BSX.

Score Leader

TrackBarclaysCap

TrackBarclaysCap (< 20) Score: +581.42

The Score Leader is the player with the highest score across all their picks in BSX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Boum < 20 7/26/2012 Outperform 5Y $4.99 +642.08% +138.38% +503.71 0 Comment
akim088 < 20 7/27/2012 Outperform 1Y $5.02 +637.65% +136.32% +501.33 1 Comment
morten1952 92.99 10/25/2012 Outperform 5Y $5.15 +619.03% +127.78% +491.24 0 Comment
eljuden21 76.48 7/30/2012 Outperform 1Y $5.18 +614.86% +133.54% +481.32 0 Comment
TessaFaye 64.81 1/4/2012 Outperform 5Y $5.32 +596.05% +154.32% +441.73 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. adamotocross48 74.35 12/12/2011 7/25/2013 Outperform 3Y $5.32 +596.05% +158.90% +437.15 0 Comment
lusito1779 < 20 1/13/2012 Outperform 5Y $5.45 +579.45% +152.01% +427.44 0 Comment
ttodisco < 20 6/27/2012 Outperform 1Y $5.55 +567.21% +144.30% +422.91 1 Comment
BooBearsDad < 20 10/26/2011 Outperform 3M $5.44 +581.32% +162.94% +418.38 0 Comment
bradford86 99.49 1/11/2012 Outperform 5Y $5.53 +569.62% +151.30% +418.32 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BSX.